• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,330.80 -180.24
(-0.36%)
Dow Jones
7,129.46 -29.44
(-0.41%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,468.22 -8.24
(-0.08%)
Forex
USD-INR
93.75 0.31
(0.34%)
EUR-INR
109.98 0.10
(0.09%)
GBP-INR
126.66 0.42
(0.33%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Medico Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540937
INE630Y01024
8.0566856
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDICO
30.14
350.11
EPS(TTM)
Face Value()
Div & Yield %
1.4
2
0
 

regis industries ltd
Nelco slumps on reporting dismal Q3 performance
Jan 16,2026

Total income declined 4.08% YoY to Rs 78.88 crore in Q3 FY26, from Rs 82.24 crore in the corresponding quarter last year.

The company reported a loss before tax of Rs 1.73 crore in Q3 FY26, against a profit before tax of Rs 6.98 crore in Q3 FY25.

Total expenses rose 2.83% YoY to Rs 70.48 crore, compared with Rs 68.54 crore in Q3 FY25. Purchase of stock-in-trade stood at Rs 14.72 crore, up 99.59% YoY during the quarter.

On a standalone basis, the company’s net profit declined 0.57% YoY to Rs 0.87 crore in Q3 FY26, compared with Rs 0.88 crore in Q3 FY25. Total income fell 4.52% YoY to Rs 50.23 crore during the quarter.

Nelco provides domestic satellite communication services to closed user group networks.